A rare case of vernakalant-induced 1:1 atrial flutter during chemical cardioversion of atrial fibrillation requiring emergency direct current cardioversion
| Autor: | Paul Stoneman, Fiona Colbert, Joseph Adams, Richard G. Sheahan |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Atrial fibrillation Cardioversion medicine.disease Vernakalant chemistry.chemical_compound chemistry Internal medicine Rare case Direct current cardioversion cardiovascular system medicine Cardiology General Earth and Planetary Sciences cardiovascular diseases business Atrial flutter General Environmental Science Chemical cardioversion |
| Zdroj: | British Journal of Cardiac Nursing. 16:1-4 |
| ISSN: | 2052-2207 |
| Popis: | Vernakalant is an atrial-selective, multi-channel anti-arrhythmic that offers a safe alternative to traditional approaches to chemical cardioversion of recent-onset, non-valvular atrial fibrillation. This case report describes a very rare occurrence of unstable accelerated 1:1 atrial flutter during an attempted cardioversion of non-valvular atrial fibrillation using vernakalant hydrochloride that required emergent direct current cardioversion. This case report highlights the need for clinicians to remain vigilant and be prepared to treat rare consequences of vernakalant administration. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|